Effects of cholesterol reduction by simvastatin and ezetimibe on muscle sympathetic nerve activity in hypertension and hypercholesterolaemia.

Trial Profile

Effects of cholesterol reduction by simvastatin and ezetimibe on muscle sympathetic nerve activity in hypertension and hypercholesterolaemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 May 2013

At a glance

  • Drugs Ezetimibe (Primary) ; Simvastatin (Primary)
  • Indications Hypercholesterolaemia; Hypertension
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 29 May 2013 New trial record
    • 18 May 2013 Results presented at the 28th Annual Scientific Meeting of the American Society of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top